Cardiovascular disease and healthy ageing

Cardiovascular diseases are main cause of morbidity and mortality in the Western World. Cardiovascular disease increases in its prevalence with age and the burden of this condition is set to increase with an Ageing global population. There are many factors that impact cardiovascular disease risk. The aim of this brief commentary is to explore some of these factors; specifically, we will examine the role of social status, nutrition and, psychological stress in modulating cardiovascular disease risk. Our aim is to emphasise the multidimensional nature of this condition and to stress that a more complete understanding of the mechanisms which underpin its pathology can only be achieved by adopting an integrated approach which treats the progression of this disease in a more holistic fashion

Mathematical Modelling of Metabolic Regulation in Aging

The underlying cellular mechanisms that characterize aging are complex and multifaceted. However, it is emerging that aging could be regulated by two distinct metabolic hubs. These hubs are the pathway defined by the mammalian target of rapamycin (mTOR) and that defined by the NAD+-dependent deacetylase enzyme, SIRT1. Recent experimental evidence suggests that there is crosstalk between these two important pathways; however, the mechanisms underpinning their interaction(s) remains poorly understood. In this review, we propose using computational modelling in tandem with experimentation to delineate the mechanism(s). We briefly discuss the main modelling frameworks that could be used to disentangle this relationship and present a reduced reaction pathway that could be modelled. We conclude by outlining the limitations of computational modelling and by discussing opportunities for future progress in this area

Mathematically modelling the dynamics of cholesterol metabolism and ageing

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the UK. This conditionbecomes increasingly prevalent during ageing; 34.1% and 29.8% of males and females respectively, over 75years of age have an underlying cardiovascular problem. The dysregulation of cholesterol metabolism isinextricably correlated with cardiovascular health and for this reason low density lipoprotein cholesterol(LDL-C) and high density lipoprotein cholesterol (HDL-C) are routinely used as biomarkers of CVD risk. Theaim of this work was to use mathematical modelling to explore how cholesterol metabolism is affectedby the ageing process. To do this we updated a previously published whole-body mathematical model ofcholesterol metabolism to include an additional 96 mechanisms that are fundamental to this biologicalsystem. Additional mechanisms were added to cholesterol absorption, cholesterol synthesis, reversecholesterol transport (RCT), bile acid synthesis, and their enterohepatic circulation. The sensitivity of themodel was explored by the use of both local and global parameter scans. In addition, acute cholesterolfeeding was used to explore the effectiveness of the regulatory mechanisms which are responsible formaintaining whole-body cholesterol balance. It was found that our model behaves as a hypo-responderto cholesterol feeding, while both the hepatic and intestinal pools of cholesterol increased significantly.The model was also used to explore the effects of ageing in tandem with three different cholesterolester transfer protein (CETP) genotypes. Ageing in the presence of an atheroprotective CETP genotype,conferring low CETP activity, resulted in a 0.6% increase in LDL-C. In comparison, ageing with a genotypereflective of high CETP activity, resulted in a 1.6% increase in LDL-C. Thus, the model has illustrated theimportance of CETP genotypes such as I405V, and their potential role in healthy ageing

Using Mathematical Modelling and Electrochemical Analysis to Investigate Age‐Associated Disease

People are living longer. With this rise in life expectancy, a concomitant rise in morbidity in later life is observed; with conditions including cardiovascular disease (CVD), and cancer. However, ageing and the pathogenesis of age related disease, can be difficult to study, as the ageing process is a complex process, which affects multiple systems and mechanisms. The aim of this research was two‐fold. The first aim was to use mathematical modelling to investigate the mechanisms underpinning cholesterol metabolism, as aberrations to this system are associated with an increased risk for CVD. To better understand cholesterol from a mechanistic perspective, a curated kinetic model of whole body cholesterol metabolism, from the BioModels database, was expanded in COPASI, to produce a model with a broader range of mechanisms which underpin cholesterol metabolism. A range of time course data, and local and global parameter scans were utilised to examine the effect of cholesterol feeding, saturated fat feeding, ageing, and cholesterol ester transfer protein (CETP) genotype. These investigations revealed: the model behaved as a hypo‐responder to cholesterol feeding, the robustness of the cholesterol biosynthesis pathway, and the impact CETP can have on healthy ageing. The second aim of this work was to use electrochemical techniques to detect DNA methylation within the engrailed homeobox 1 (EN1) gene promoter, which has been implicated in cancer. Hypermethylation of this gene promoter is often observed in a diseased state. Synthetic DNA, designed to represent methylated and unmethylated variants, were adsorbed onto a gold rotating disk electrode for electrochemical analysis by 1) electrochemical impedance spectroscopy (EIS), 2) cyclic voltammetry (CV) and 3) differential pulse voltammetry (DPV). The technique was then applied to bisulphite modified and asymmetrically amplified DNA from the breast cancer cell line MCF‐7. Results indicated that electrochemical techniques could detect DNA methylation in both synthetic and cancer derived DNA, with EIS producing superiorresults. These non‐traditional techniques ofstudying age related disease were effective for the investigation of cholesterol metabolism and DNA methylation, and this work highlights how these techniques could be used to elucidate mechanisms or diagnose/monitor disease pathogenesis, to reduce morbidity in older peopl